Literature DB >> 28097239

Metastasis regulation by PPARD expression in cancer cells.

Xiangsheng Zuo1, Weiguo Xu1,2, Min Xu1, Rui Tian1, Micheline J Moussalli3, Fei Mao1, Xiaofeng Zheng4, Jing Wang4, Jeffrey S Morris5, Mihai Gagea6, Cathy Eng1, Scott Kopetz1, Dipen M Maru3, Asif Rashid3, Russell Broaddus3, Daoyan Wei7, Mien-Chie Hung8, Anil K Sood9,10,11, Imad Shureiqi1.   

Abstract

Peroxisome proliferator-activated receptor-δ (PPARD) is upregulated in many major human cancers, but the role that its expression in cancer cells has in metastasis remains poorly understood. Here, we show that specific PPARD downregulation or genetic deletion of PPARD in cancer cells significantly repressed metastasis in various cancer models in vivo. Mechanistically, PPARD promoted angiogenesis via interleukin 8 in vivo and in vitro. Analysis of transcriptome profiling of HCT116 colon cancer cells with or without genetic deletion of PPARD and gene expression patterns in The Cancer Genome Atlas colorectal adenocarcinoma database identified novel pro-metastatic genes (GJA1, VIM, SPARC, STC1, SNCG) as PPARD targets. PPARD expression in cancer cells drastically affected epithelial-mesenchymal transition, migration, and invasion, further underscoring its necessity for metastasis. Clinically, high PPARD expression in various major human cancers (e.g., colorectal, lung, breast) was associated with significantly reduced metastasis-free survival. Our results demonstrate that PPARD, a druggable protein, is an important molecular target in metastatic cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28097239      PMCID: PMC5214933          DOI: 10.1172/jci.insight.91419

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  72 in total

1.  STC1 expression is associated with tumor growth and metastasis in breast cancer.

Authors:  Andy C-M Chang; Judy Doherty; Lily I Huschtscha; Richard Redvers; Christina Restall; Roger R Reddel; Robin L Anderson
Journal:  Clin Exp Metastasis       Date:  2014-11-13       Impact factor: 5.150

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

3.  PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells.

Authors:  Eunshil Jeong; Jung Eun Koo; Sang Hyeon Yeon; Mi-Kyoung Kwak; Daniel H Hwang; Joo Young Lee
Journal:  Mol Carcinog       Date:  2014-03-09       Impact factor: 4.784

4.  Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.

Authors:  Lie Yang; Hong Zhang; Zong-Guang Zhou; Hui Yan; G Adell; Xiao-Feng Sun
Journal:  Clin Cancer Res       Date:  2011-04-29       Impact factor: 12.531

5.  Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.

Authors:  Scott Kopetz; Paulo M Hoff; Jeffrey S Morris; Robert A Wolff; Cathy Eng; Katrina Y Glover; Rosie Adinin; Michael J Overman; Vincete Valero; Sijin Wen; Christopher Lieu; Shaoyu Yan; Hai T Tran; Lee M Ellis; James L Abbruzzese; John V Heymach
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

6.  Transcriptional network governing the angiogenic switch in human pancreatic cancer.

Authors:  Amir Abdollahi; Christian Schwager; Jörg Kleeff; Irene Esposito; Sophie Domhan; Peter Peschke; Kai Hauser; Philip Hahnfeldt; Lynn Hlatky; Jürgen Debus; Jeffrey M Peters; Helmut Friess; Judah Folkman; Peter E Huber
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

7.  Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.

Authors:  Xiangsheng Zuo; Zhanglong Peng; Micheline J Moussalli; Jeffrey S Morris; Russell R Broaddus; Susan M Fischer; Imad Shureiqi
Journal:  J Natl Cancer Inst       Date:  2009-05-12       Impact factor: 13.506

8.  Connexin 43, but not connexin 32, is mutated at advanced stages of human sporadic colon cancer.

Authors:  Michael V Dubina; Nikolay A Iatckii; Dimitrii E Popov; Sergei V Vasil'ev; Vladimir A Krutovskikh
Journal:  Oncogene       Date:  2002-07-25       Impact factor: 9.867

9.  Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model.

Authors:  C Schneider; T Schmidt; C Ziske; K Tiemann; K-M Lee; V Uhlinsky; P Behrens; T Sauerbruch; I G H Schmidt-Wolf; P F Mühlradt; J Schmidt; A Märten
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

10.  Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.

Authors:  Yasuhiro Ito; Yuichi Oike; Kunio Yasunaga; Koichi Hamada; Keishi Miyata; Shun-Ichiro Matsumoto; Sumio Sugano; Hidenobu Tanihara; Yasuhiko Masuho; Toshio Suda
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

View more
  32 in total

1.  PPARδ Mediates the Effect of Dietary Fat in Promoting Colorectal Cancer Metastasis.

Authors:  Dingzhi Wang; Lingchen Fu; Jie Wei; Ying Xiong; Raymond N DuBois
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

2.  PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice.

Authors:  Xiangsheng Zuo; Yasunori Deguchi; Weiguo Xu; Yi Liu; Haiyan S Li; Daoyan Wei; Rui Tian; Weidong Chen; Min Xu; Yaying Yang; Shen Gao; Jonathan C Jaoude; Fuyao Liu; Sarah P Chrieki; Micheline J Moussalli; Mihai Gagea; Manu M Sebastian; Xiaofeng Zheng; Dongfeng Tan; Russell Broaddus; Jing Wang; Nadim J Ajami; Alton G Swennes; Stephanie S Watowich; Imad Shureiqi
Journal:  Gastroenterology       Date:  2019-03-15       Impact factor: 22.682

3.  Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis.

Authors:  Kelly E Johnson; Julia R Ceglowski; Harvey G Roweth; Jodi A Forward; Mason D Tippy; Saleh El-Husayni; Rajesh Kulenthirarajan; Michael W Malloy; Kellie R Machlus; Wendy Y Chen; Joseph E Italiano; Elisabeth M Battinelli
Journal:  Blood Adv       Date:  2019-01-22

Review 4.  Contribution of RAGE axis activation to the association between metabolic syndrome and cancer.

Authors:  Ma Eugenia Garay-Sevilla; Armando Gomez-Ojeda; Ileana González; Claudia Luévano-Contreras; Armando Rojas
Journal:  Mol Cell Biochem       Date:  2021-01-04       Impact factor: 3.396

5.  DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.

Authors:  Yue Guo; Renyi Wu; John M Gaspar; Davit Sargsyan; Zheng-Yuan Su; Chengyue Zhang; Linbo Gao; David Cheng; Wenji Li; Chao Wang; Ran Yin; Mingzhu Fang; Michael P Verzi; Ronald P Hart; Ah-Ng Kong
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

Review 6.  PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal-Epithelial Crosstalk and Carcinogenesis.

Authors:  Hong Sheng Cheng; Yun Sheng Yip; Eldeen Kai Yi Lim; Walter Wahli; Nguan Soon Tan
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

7.  Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma.

Authors:  Ran Jia; Zhilin Sui; Hongdian Zhang; Zhentao Yu
Journal:  Front Mol Biosci       Date:  2021-05-24

Review 8.  The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone.

Authors:  Jonathan D Diedrich; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

9.  Aberrant Expression of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer and Their Association with Cancer Progression and Prognosis.

Authors:  Musa Yaghoubizadeh; Leila Pishkar; Gholam Basati
Journal:  Gastrointest Tumors       Date:  2019-11-01

10.  Suppression of Membranous LRP5 Recycling, Wnt/β-Catenin Signaling, and Colon Carcinogenesis by 15-LOX-1 Peroxidation of Linoleic Acid in PI3P.

Authors:  Fuyao Liu; Xiangsheng Zuo; Yi Liu; Yasunori Deguchi; Micheline J Moussalli; Weidong Chen; Peiying Yang; Bo Wei; Lin Tan; Philip L Lorenzi; Shen Gao; Jonathan C Jaoude; Amir Mehdizadeh; Lovie Ann Valentin; Daoyan Wei; Imad Shureiqi
Journal:  Cell Rep       Date:  2020-08-18       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.